Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
2
M Ventures, Walnut Venture Associates
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Apr 22, 2020 Launched Akili Interactive launches ADHD treatment game · businesswire.com
Tractionpublic signals, read monthly
Hacker News stories
1
best: 2 points
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Octagon TherapeuticsVenture round $11M · 2 yr ago • Founded 2016 • 11-50 employees
A biotech company developing better medicines for patients with autoimmune and inflammatory diseases. Leveraging powerful insights into the…
ShopFullyVenture round $10.8M · 11 yr ago • 201-500 employees • 5 roles
Shopfully. The leading tech company in Drive To Store. We work with the best tech and people to reinvent local shopping and take it to the…
Better medicine, fast.. Partner with us.
Exonic – AI for adaptive medicine.. AI for adaptive medicine.
At Laurus, our mission is to reinvent urban farming and provide a sustainable way of offering hyper-local, fresh and affordable food to…
Our Services | 替身醫療. 替身醫療(Avatar medicine)是透過收集患者的檢體或數據,建立出「替身」代替患者嘗試不同的治療,減少用藥風險,提高用藥精準。…

Overview

Akili Interactive is a prescription digital medicine company combining scientific and clinical rigor with the ingenuity of the tech industry to reinvent medicine.

News

News STAT 3 years ago
Akili Interactive releases video game treatment for adult ADHD with no prescription required
Akili Interactive will release its video game treatment, EndeavorRx, for adults with ADHD, taking advantage of FDA flexibilities.
Read more
Report
News Akili Interactive 6 years ago
Akili Announces FDA Clearance of EndeavorRx for Children with ADHD, the First Prescription Treatment Delivered Through a Video Game
Shown to improve attention function, EndeavorRx is backed by data from five clinical studies, including a prospective, randomized controlled trial BOSTON, Mass - June 15, 2020 - Akili today announced that the U.S. Food and Drug Administration (FDA) has gr
Read more
Report